Ryvu Therapeutics Sa Stock Current Valuation

RVU Stock   45.30  0.30  0.67%   
Valuation analysis of Ryvu Therapeutics helps investors to measure Ryvu Therapeutics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
RVU.WAR fundamentals not found at this time

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Pair Trading with Ryvu Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ryvu Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ryvu Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ryvu Stock

  0.78PKN Polski Koncern NaftowyPairCorr

Moving against Ryvu Stock

  0.84CEZ CEZ asPairCorr
  0.65DNP Dino Polska SAPairCorr
  0.62UCG UniCredit SpAPairCorr
  0.42SAN Banco Santander SAPairCorr
The ability to find closely correlated positions to Ryvu Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ryvu Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ryvu Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ryvu Therapeutics SA to buy it.
The correlation of Ryvu Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ryvu Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ryvu Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ryvu Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Ryvu Stock Analysis

When running Ryvu Therapeutics' price analysis, check to measure Ryvu Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryvu Therapeutics is operating at the current time. Most of Ryvu Therapeutics' value examination focuses on studying past and present price action to predict the probability of Ryvu Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryvu Therapeutics' price. Additionally, you may evaluate how the addition of Ryvu Therapeutics to your portfolios can decrease your overall portfolio volatility.